ITNS OTC
Itonis, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -20.0%
1Y: +33.3%
3Y: -11.1%
5Y: -86.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.6M
52W Range0.0002-0.000600000028
Volume130,000
Avg Volume243,606
Beta0.26
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMark H. Cheung
Employees3
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2007-02-21
Websiteitonisholdings.com
22951 Mill Creek Drive
Laguna Hills, CA 92653
US
Laguna Hills, CA 92653
US
949-200-8887
About Itonis, Inc.
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Latest News
No recent news
Recent Insider Trades
No insider trades found